-
Expansion and deceleration? Lilly's first acquisition within the year: $3.2 billion to increase investment in the IBD market
On July 8th local time, 21st Century Business Herald reporter Han Liming (NYSE: LLY) announced that it will acquire all outstanding shares of Morphic (totaling approximately $3.2 billion) for $57 per ...